Reply to: Comment on: Ototoxicity in Pediatric Hematopoietic Stem Cell Transplantation With High Dose Carboplatin: Identifying Modifiable Risk Factors Through the Inclusion of Younger Patients

IF 2.3 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2025-08-25 DOI:10.1002/pbc.32008

Anne Spence, Miranda Camet, Susan S. Hayashi, Mary Claire McGlynn, Ningying Wu, Robert J. Hayashi

引用次数: 0

Abstract Image

查看原文本刊更多论文

评论：高剂量卡铂儿童造血干细胞移植的耳毒性：通过纳入年轻患者确定可改变的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.